Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,400
Closed -$965K 3
2026
Q1
$965K Buy
+9,400
New +$1.06M 0.04% 63
2023
Q1
Sell
-3,600
Closed -$395K 8
2022
Q4
$395K Sell
3,600
-40,100
-92% -$4.15M 0.05% 60
2022
Q3
$4.23M Buy
43,700
+17,400
+66% +$1.85M 0.35% 43
2022
Q2
$2.86M Sell
26,300
-40,300
-61% -$4.58M 0.21% 64
2022
Q1
$7.88M Buy
+66,600
New +$8.26M 0.3% 62
2021
Q4
Sell
-21,800
Closed -$2.58M 21
2021
Q3
$2.58M Buy
21,800
+15,600
+252% +$1.92M 0.17% 89
2021
Q2
$719K Buy
6,200
+1,600
+35% +$187K 0.07% 141
2021
Q1
$552K Buy
4,600
+2,400
+109% +$284K 0.05% 39
2020
Q4
$242K Buy
+2,200
New +$239K 0.02% 51

Other funds holding ABT

QVR's ABT Position: Q4 2022 in Review

QVR sold out of Abbott (ABT) in Q4 2022, closing a stake of 16,675 shares — an estimated $1.73M sold.

QVR first reported a position in ABT in Q3 2021 and held it in 4 quarters. The position peaked at $1.61M in Q3 2022. 2,764 funds tracked by Wall St. Rank hold ABT as of Q4 2022.

  • QVR reported no remaining Abbott position as of Q4 2022 after selling out during the quarter.
  • QVR sold 16,675 Abbott shares in Q4 2022, an estimated $1.73M.
  • QVR first reported a position in Abbott in Q3 2021 and held it in 4 quarters.
  • QVR's Abbott position peaked at $1.61M in Q3 2022.
  • 2,764 funds tracked by Wall St. Rank held Abbott as of Q4 2022.

Based on QVR's 13F filing for Q4 2022, filed 10 Feb 2023.